Altamimi et al. demonstrated that EA prevented kidney injury, inflammation, and oxidative stress in a STZ-induced diabetic nephropathy model by enhancing the transcriptional activation of Nrf2 and reducing its interaction with Keap1 [44]. Here, KEAP1 is linked to diabetic kidney disease.